Sagent Pharma Cash Flow - Quarterly (NASDAQ:SGNT)

Add to My Stocks
$21.76 $0.03 (0.14%) SGNT stock closing price Aug 29, 2016 (Closing)

The financial analysis of SGNT requires an investor to check the cash flows for Sagent Pharma. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Sagent Pharma profits and Sagent Pharma debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Sagent Pharma stock analysis. Sagent Pharma generated $-14.79M cash from operating activities in till this quarter of 2016 Q2. Sagent Pharma saw a outflow of $-4.06M from investing activities till 2016 Q2.

View and download details of Sagent Pharma cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow4.41M1.7M13.68M
Net Increase (Decrease) in Assets Liabilities-19M-18.57M-18.83M
Cash From (used in) Discontinued Operations---
Other Adjustments Net5.3M5.23M19.51M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-6.05M-2.33M-6.71M
Acquisition Disposition of Subsidiaires-1.69M-1.69M-11.78M
Increase (Decrease) in Investments-0.11M--1.79M
Other Cash Inflow (Outflow) from Investment Activities3.8M2M-1.7M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--9.34M
Issuance (Repayment) of Debt Securities4.8M1.55M-0.47M
Increase (Decrease) in Bank & Other Borrowings---5.18M
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-0.2M-0.07M-0.18M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---0.65M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year7.73M25.65M-
Cash & Equivalents at Year End15.52M12.5M28.96M
All figures in USD. M: Millions of USD, B: Billions of USD.

Sagent Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Sagent Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Sagent Pharma has cash of $15.52M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Sagent Pharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Sagent Pharma lost $-14.79M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-4.06M for SGNT stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $4.69M for Sagent Pharma.